Papers: 10.1038/s41598-020-64755-1

https://doi.org/10.1038/s41598-020-64755-1

Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer’s disease risk

Cited by: 6
Author(s): Josue D. Gonzalez Murcia, Allen Weinert, Claudia M. Tellez Freitas, Daniel K. Arens, Meganne Ferrel, Julianne H. Grose, Perry G. Ridge, Eric Wilson, John Kauwe, K. Scott Weber
Published: about 5 years ago

Software Mentions 2